Deakin University
Browse

New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors

Version 2 2024-05-30, 15:38
Version 1 2014-10-28, 09:44
journal contribution
posted on 2024-05-30, 15:38 authored by M Maes, Z Fišar, M Medina, G Scapagnini, G Nowak, Michael BerkMichael Berk
New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors

History

Journal

Inflammopharmacology

Volume

20

Pagination

127-150

Location

Switzerland

ISSN

0925-4692

eISSN

1568-5608

Language

en

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

2012, Springer Basel AG

Issue

3

Publisher

Springer Science and Business Media LLC